How DCT Adoption Is Like A New Relationship
Source: Clinical Leader
Has the luster of DCTs and their associated technologies started to wear off? Phil Ambrey, global clinical head at AstraZeneca thinks that is exactly what we’re seeing today.
View the full presentation here.
This website uses cookies to ensure you get the best experience on our website. Learn more